Ischemic preconditioning of the liver: A few perspectives from the bench to bedside translation

Authors:

Abstract
Utilization of ischemic preconditioning to ameliorate ischemia/reperfusion injury has been extensively studied in various organs and species for the past two decades. While hepatic ischemic preconditioning in animals has been largely beneficial, translational efforts in the two clinical contexts—liver resection and decreased donor liver transplantation—have yielded mixed results. This review is intended to critically examine the translational data and identify some potential reasons for the disparate clinical results, and highlight some issues for further studies. Liver Transpl 14:1569–1577, 2008. © 2008 AASLD.

This publication has 80 references indexed in Scilit: